HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

An Expert’s Guide To Switching In Germany, Part 1: Navigating The Reclassification Process

Executive Summary

Elmar Kroth, scientific director of the German Medicines Manufacturers´ Association, the BAH, talks exclusively to HBW Insight about prescription-to-OTC switching in Germany and the association’s efforts to improve this process.

Advertisement

Related Content

An Expert’s Guide To Switching In Germany, Part 2: Improving The Reclassification Process
An Expert’s Guide To Switching In Germany, Part 2: Improving The Reclassification Process
Switchers, apply here, says HPRA
Rowex launches OTC sumatriptan in Ireland
A quarter of a century in OTC
Three switches for Germany

Topics

Advertisement
UsernamePublicRestriction

Register

RS139904

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel